1996
DOI: 10.1126/science.271.5256.1723
|View full text |Cite
|
Sign up to set email alerts
|

Neonatal Tolerance Revisited: Turning on Newborn T Cells with Dendritic Cells

Abstract: For some time it has been thought that antigenic challenge in neonatal life is a tolerogenic rather than immunogenic event. Reexamination of the classic neonatal tolerance experiments of Billingham, Brent, and Medawar showed that tolerance is not an intrinsic property of the newborn immune system, but that the nature of the antigen-presenting cell determines whether the outcome is neonatal tolerance or immunization.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

26
437
1
8

Year Published

1997
1997
2010
2010

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 731 publications
(472 citation statements)
references
References 52 publications
26
437
1
8
Order By: Relevance
“…We can attempt to convert tumour cells to antigenpresenting cells by making them more immunogenic (B7 co-stimulation); restore lost MHC molecules; transfect with cytokines capable of a direct stimulation of lymphocytes (IL-2) or even enhance tumour antigen release and its subsequent up-take by professional antigen-presenting cells (presuming that antigenspecific T cells are still in the circulation or can be generated from naive precursors). The last approach also conforms with a recently suggested 'Danger Model' (Ridge et al, 1996) theory according to which induced necrosis may attract antigen-presenting cells (macrophages, dendritic cells), increase their up-take and the subsequent delivery of antigen in an appropriate fashion to T lymphocytes. The recruitment of antigen-presenting cells can be further potentiated by the local production of GM-CSF or IL-12.…”
Section: Gene and Adoptive Immunotherapysupporting
confidence: 70%
“…We can attempt to convert tumour cells to antigenpresenting cells by making them more immunogenic (B7 co-stimulation); restore lost MHC molecules; transfect with cytokines capable of a direct stimulation of lymphocytes (IL-2) or even enhance tumour antigen release and its subsequent up-take by professional antigen-presenting cells (presuming that antigenspecific T cells are still in the circulation or can be generated from naive precursors). The last approach also conforms with a recently suggested 'Danger Model' (Ridge et al, 1996) theory according to which induced necrosis may attract antigen-presenting cells (macrophages, dendritic cells), increase their up-take and the subsequent delivery of antigen in an appropriate fashion to T lymphocytes. The recruitment of antigen-presenting cells can be further potentiated by the local production of GM-CSF or IL-12.…”
Section: Gene and Adoptive Immunotherapysupporting
confidence: 70%
“…20 Its establishment appears to be confined to a special phase during fetal and early development, when the immune system is prone to tolerate antigens rather than making classical immune responses. 20 Many hypotheses have been raised to explain it, 20,21 including that neonatal tolerance results from a T-cell inability to produce IL-2, 22,23 from the high numbers of non-functional immature T cells and low numbers of mature effector T cells, 20 from lack of professional antigen-presenting cells, 24,25 and from the high activity of suppressor cells. 26 More recently, it has been proposed that T-cell migration patterns in a neonatal environment might be of importance in establishing tissue-specific tolerance at birth.…”
Section: Discussionmentioning
confidence: 99%
“…[32][33][34] However, it has been demonstrated that, under optimal costimulatory conditions or with allogenic dendritic cells, neonatal and adult T-cell responses are similar, showing the immunocompetence of the T cells. 34,35 The increased susceptibility of neonates to infections in general has been ascribed to the immaturity of their immune system, and, more specifically, to the particular conditions of antigen presentation and T-cell priming. 36,37 In agreement with these results, we found that APCs isolated from the spleens and mesenteric lymph nodes of aa-fed adult C57BL/6 mice expressed CD40, CD80 and CD86 at levels similar to those of APCs from suckling mice.…”
Section: Discussionmentioning
confidence: 99%